Top News

Jul 27, 2016
The Phase I trial will test Bavarian Nordic’s vaccine, which is manufactured using a vaccine vector based on smallpox.
Jul 25, 2016
The vaccine candidate has also won a Priority Medicines (PRIME) status from EMA.
Jul 21, 2016
A new website collects and rates information about life-science supplies from academic journals to simplify researcher purchasing decisions.
Jul 21, 2016
Amgen and Allergan’s biosimilar to popular breast cancer drug Herceptin is comparable to the innovator molecule, Amgen recently announced.
Jul 20, 2016
Thirty percent of current Remicade patients could be eligible for a switch to competitors such as Inflectra, according to estimates, although J&J doubts this will occur in the United States in 2016.
Jul 19, 2016
By BioPharm International Editors
The company received prequalification for its Prevenar 13 MDV, which allows global use of the vaccine by United Nations countries and agencies.
Jul 12, 2016
By BioPharm International Editors
EAG Laboratories announces new company identity and intent to expand testing, analysis, and characterization capabilities across multiple markets.
Jul 11, 2016
FDA reviewers have found that Sandoz's GP2015, a biosimilar version of Amgen's Enbrel, is highly similar to the original product in terms of purity, safety, and potency.
Jul 11, 2016
By BioPharm International Editors
Patheon launches initial public offering to repay outstanding notes and expenses.
Jul 08, 2016
A Federal Circuit court ruled biosimilar makers must wait 180 days after receiving FDA approval before bringing drugs to market.
lorem ipsum